Ledger.Open graph →
SEC Form D · Amendment · filed August 25, 2021

NERVGEN PHARMA CORP

Offering
$5.4M
Sold
$2.2M
Exemption
Rule 506(b)
Industry
Other
Location
VANCOUVER, British Columbia, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Daniel Mikol · Vancouver, British Columbia, CanadaExecWilliam Adams · Vancouver, British Columbia, CanadaExecHarold J. Punnett · Vancouver, British Columbia, CanadaDirectorBrian J. Bayley · Vancouver, British Columbia, CanadaDirectorRandall Kaye · Vancouver, British Columbia, CanadaDirectorBill Radvak · Vancouver, British Columbia, CanadaDirectorPaul Brennan · Vancouver, British Columbia, CanadaExec · DirectorMichael Abrams · Vanouver, British Columbia, CanadaDirectorJane N. Wilkinson · Luxembourg, LuxembourgExecRichard R. Halderman · Zionsville, INDirectorRoger Tichenor · Sarasota, FLDirectorRod W. Saddington · DALLAS, TXExec · DirectorBesar N. Muhameti · Luxembourg, LuxembourgDirectorZarrell R. Gray · Zionsville, INDirectorBruce Cassidy · Sarasota, FLDirectorJacob L. Block · Grove City, OHExecAndrew Hemingway · Bristol, NHDirectorMLG Fund Manager LLC · Brookfield, WIDirectorYuriy Gordiyenko · Brooklyn, NYDirectorMikhail Zlotnik · Brooklyn, NYDirectorYuriy Novodvorskiy · Brooklyn, NYExec · DirectorAlina Trigub · Brooklyn, NYExecDaniel A. Gold · New York, NYDirectorBrent E. Carey · Long Beach, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗